Cargando…
Sirolimus-eluting cobalt–chrome alloy stent suppresses stent-induced tissue hyperplasia in a porcine Eustachian tube model
Various preclinical studies with developed Eustachian tube (ET) stents are in progress but have not yet been clinically applied. ET stent is limited by stent-induced tissue hyperplasia in preclinical studies. The effectiveness of sirolimus-eluting cobalt–chrome alloy stent (SES) in suppressing stent...
Autores principales: | Kang, Jeon Min, Kim, Song Hee, Choi, Yeon Joo, Park, Yubeen, Ryu, Dae Sung, Kang, Woo Seok, Park, Jung-Hoon, Park, Hong Ju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891339/ https://www.ncbi.nlm.nih.gov/pubmed/35236923 http://dx.doi.org/10.1038/s41598-022-07471-2 |
Ejemplares similares
-
Preliminary results of absorbable magnesium stent for treating eustachian tube dysfunction in a porcine model
por: Kang, Jeon Min, et al.
Publicado: (2023) -
Tapered self-expandable metallic stent optimized for Eustachian tube morphology in a porcine ET model
por: Kang, Jeon Min, et al.
Publicado: (2022) -
Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
por: Kim, Byeong-Keuk, et al.
Publicado: (2010) -
Neointimal hyperplasia persists at six months after sirolimus-eluting stent implantation in diabetic porcine
por: Zhang, Qi, et al.
Publicado: (2007) -
Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
por: Kim, Ung, et al.
Publicado: (2011)